3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Breast
1
Conditions
Breast Neoplasms
51
Neoplasms
36
Lung Neoplasms
25
Colorectal Neoplasms
24
Prostatic Neoplasms
15
Uterine Cervical Neoplasms
14
Motor Activity
13
Colonic Neoplasms
11
Rectal Neoplasms
9
Pancreatic Neoplasms
9
Hematologic Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Anxiety Disorders
9
Obesity
8
Lymphoma
8
Depression
8
Endometrial Neoplasms
7
Vulvar Neoplasms
6
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Melanoma
6
Head and Neck Neoplasms
6
Breast Carcinoma In Situ
6
Pain
5
Neoplasm Metastasis
5
Leukemia, Myeloid, Acute
5
Hematopoietic and Lymphatic System Neoplasm
5
Triple Negative Breast Neoplasms
4
Smoking Cessation
4
Papillomavirus Infections
4
Interventions
veliparib
2
Salpingo-oophorectomy
2
Genetic Testing
2
Genetic Counseling
2
Diet, Mediterranean
2
Counseling
2
Carboplatin
2
prexasertib
1
Zoledronic Acid
1
Videotape Recording
1
Telemedicine
1
Taxes
1
Tamoxifen
1
Standard of Care
1
Specimen Handling
1
Salpingectomy
1
Psychiatric Rehabilitation
1
Practice Guidelines as Topic
1
Palliative Care
1
Paclitaxel
1
Ovariectomy
1
Methods
1
Letrozole
1
Genotype
1
Early Intervention, Educational
1
Docetaxel
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hereditary Breast and Ovarian Cancer Syndrome
×
Methods
×
Clear all
NCT07236359
2025-11-19
Reborn-i
Beaumont Hospital
Phase NA
Not yet recruiting
108 enrolled